Indiamed Globals

• Calutide 50mg (Genric Casodex) is an anti-androgen. It works in the body by preventing the actions of androgens (male hormones)
• Calutide 50mg (Genric Casodex) is used together with another hormone to treat prostate cancer
• Calutide 50mg (Genric Casodex) may also be used for purposes not listed in this medication guide
• Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat
• Oral consumption
• permitted chemical compounds
• Competitive prices

Product Description:
Vincristine 1mg is an injectable chemotherapy medication used primarily in the treatment of various cancers, including leukemia, lymphoma, and other malignancies. It works by inhibiting the growth of cancer cells by blocking cell division, making it a crucial drug in combination cancer therapies.

Indications for Vincristine include:

• Leukemia
• Hodgkin’s and non-Hodgkin’s lymphoma
• Wilms’ tumor
• Neuroblastoma

Dosage and Administration:

• Vincristine is administered via intravenous injection, usually once a week, and the dosage is determined based on the patient's body surface area and condition. Treatment duration varies depending on the type and stage of cancer being treated.

Common side effects of Vincristine may include:

• Numbness or tingling in hands and feet (peripheral neuropathy)
• Hair loss
• Constipation

Packaging:
Vincristine 1mg is typically available in 1mg/1ml sterile injection vials for single-use.

Vincristine is an essential part of many chemotherapy regimens due to its effectiveness in stopping cancer cell growth.

• Prostate cancer

Inclisiran 284 mg Injection contains Inclisiran, a small interfering RNA (siRNA) medication used to lower cholesterol levels in the blood. It is specifically indicated for the treatment of hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH) and atherosclerotic cardiovascular disease (ASCVD) in adults who require additional lowering of LDL cholesterol.

Inclisiran is available in a strength of 284 mg per injection and is typically packaged as a single-use pre-filled syringe. This convenient packaging allows for easy administration, usually performed by a healthcare professional.

The active ingredient, Inclisiran, works by targeting and degrading the messenger RNA (mRNA) that encodes for the protein PCSK9 (proprotein convertase subtilisin/kexin type 9). By reducing the production of PCSK9, Inclisiran increases the number of LDL receptors on the surface of liver cells, enhancing the clearance of LDL cholesterol from the blood. This mechanism of action leads to a significant reduction in LDL cholesterol levels.

The usual dosage of Inclisiran involves an initial injection, followed by a second dose at 3 months, and subsequent doses every 6 months. This biannual dosing schedule offers a convenient and effective approach to managing cholesterol levels, especially for patients who may have difficulty adhering to daily medications.

Common side effects of Inclisiran may include injection site reactions, such as redness, pain, or swelling. These side effects are generally mild and temporary. However, any severe or persistent side effects should be reported to a healthcare provider promptly.

Inclisiran is manufactured by Novartis Pharmaceuticals, a leading global healthcare company known for its innovative treatments and commitment to improving patient outcomes. Regular monitoring of cholesterol levels and follow-ups with the healthcare provider are essential to assess the effectiveness of Inclisiran and make any necessary adjustments to the treatment plan.

Inclisiran 284 mg Injection provides a groundbreaking solution for managing high cholesterol levels, particularly in patients with ASCVD and familial hypercholesterolemia. Its novel siRNA mechanism offers a new approach to cholesterol reduction, helping to reduce the risk of cardiovascular events and improve overall cardiovascular health. With its convenient dosing schedule and proven efficacy, Inclisiran represents a significant advancement in lipid management therapy.

• Prostate cancer
• Breast cancer
• Endometriosis
• Uterine fibroids
• Female infertility

Bharglob 16.5% Injection has been shown to be effective in preventing infections in bone marrow transplant patients more than 20 years of age in the first 100 days post-transplant. It is used in the treatment of patients where antibody-forming capacity is severely impaired thereby subjecting them to a greater risk of infections. Bharglob 16.5% Injection gives you antibodies that your body is not making on its own so you can fight infections. Both children and adults can have this therapy. It is administered as an injection. Your doctor will monitor you for some time after the administration of Bharglob 16.5% Injection to check for any side effects.

Bharglob 16.5% Injection may sometimes cause side effects like jnjection site reactions such as swelling, redness, pain, induration, itching, bruising, and rash and flushing (sense of warmth in the face, ears, neck, and trunk), . If you get any of these, or other side effects, or just feel unwell, you should tell your doctor. There may be ways of preventing or reducing these effects.

Before using it, you should tell your doctor if you have any problems with blood clotting and if you have recently had, or plan to have, a vaccination. It is not known whether this medicine is completely safe during pregnancy or breastfeeding so please take advice from your doctor.

• Immunoglobulins deficiency

• Flushing (sense of warmth in the face, ears, neck and trunk)
• Injection site reactions (pain, swelling, redness)
• Injection site soreness
• Injection site bruising
• Induration (hardening of a normally soft tissue or organ)
• Itching
• Rash

• Pancreatic cancer
• Breast cancer
• Non-small cell lung cancer
• Stomach cancer

• In Pancreatic cancer Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body’s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Mitomycin 40mg Injection helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life. In Breast cancer
• Mitomycin 40mg Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Mitomycin 40mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.In Non-small cell lung cancerNon-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Mitomycin 40mg Injection helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
• In Stomach cancer Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Mitomycin 40mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

Product Name: Qutan 50 Tablet Brand Name: Qutan, , Qutipin Composition: Quetiapine (50mg) Manufacturer/Marketer: Intas Pharmaceuticals Ltd Packaging: To be provided (specify packaging details if available) Treatment: Schizophrenia, bipolar disorder, depression (adjunct therapy) Product Description: Qutan 50 Tablet contains Quetiapine, an atypical antipsychotic used to treat schizophrenia and bipolar disorder. It helps stabilize mood, reduce hallucinations, and improve concentration by balancing certain neurotransmitters in the brain. It may also be prescribed as adjunct therapy for depression i will provide you name of product, content/composition, manufacturer. you have to arrange it in above format. above is already drafted for another medicine you just have to consider main points not data. for brand names, you have to fill top 3 brand names by which that content is popular, like the content semaglutide is widely popular as brand names, Rybelsus, ozempic, Wegovy (these are the top 3 names) ChatGPT said:ChatGPTMemory updated

Got it! Please provide the product name, composition, and manufacturer details for the next entry, and I'll format it accordingly.

 4oYou said:Ipoget 1 gm Injection Composition IFOSFAMIDE-1000MG + MESNA-200MG Manufacturer/Marketer GLS Pharma Ltd 129/129ChatGPT said:ChatGPT

Here’s the formatted information:

Product Name: Ipoget 1 gm Injection
Brand Names: Ipoget, Holoxan, Ifosfamide Ebewe

Composition: IFOSFAMIDE (1000mg) + MESNA (200mg)
Manufacturer/Marketer: GLS Pharma Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Cancer (testicular cancer, sarcomas, and other solid tumors)

Product Description: Ipoget 1 gm Injection contains Ifosfamide and Mesna. Ifosfamide is an alkylating agent used in chemotherapy for treating various cancers. Mesna is included to protect the bladder from harmful effects of Ifosfamide by reducing the risk of hemorrhagic cystitis

Femistra 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. It is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.

The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.

If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.

• Hormone-dependent breast cancer in postmenopausal women.

Therapeutic Effects of Femistra 1mg Tablet

Femistra 1mg tablet reduces the amount of estrogen which is produced by the body. It does this by inhibiting aromatase, the enzyme that is naturally present in your body. This can stop or reduce the growth of different breast cancer cells, which depends on estrogen. 

Inform your healthcare provider about all your medicines, including prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Femistra 1mg tablet and reduce effectiveness by causing undesirable side effects. 

• Keep the tablets away from light and moisture.
• Store at room temperature not exceeding 30°C.
• Keep the tablets out of the reach of children and animals.

Swallow the tablet whole with water. Avoid chewing, breaking, or crushing it. Take this tablet every day at the same time as prescribed by your doctor. You can take Femistra 1mg tablet with, without, or after food at any time.

• Product Description: Dasamed 50mg Tablet contains Dasatinib, a kinase inhibitor used in the treatment of certain types of leukemia. It works by inhibiting the growth of cancer cells, thereby slowing or stopping the progression of the disease. Commonly prescribed for chronic myeloid leukemia and acute lymphoblastic leukemia, Dasatinib is an essential part of targeted cancer therapy

Product Description:
Aggramed Tirofiban Injection contains Tirofiban, a glycoprotein IIb/IIIa inhibitor used in the management of acute coronary syndrome (ACS). It is indicated for use in patients experiencing non-ST elevation myocardial infarction (NSTEMI) or undergoing percutaneous coronary intervention (PCI). Tirofiban works by inhibiting platelet aggregation, which helps to prevent the formation of blood clots that can lead to heart attacks.

Aggramed is available in a concentration of 0.25 mg/ml and is typically packaged in single-use vials. This form allows for precise dosing and administration by healthcare professionals in a clinical setting.

Tirofiban, the active ingredient in Aggramed, blocks the glycoprotein IIb/IIIa receptors on the surface of platelets. These receptors are critical for platelet aggregation and thrombus formation. By inhibiting these receptors, Tirofiban reduces the risk of thrombotic events, thereby improving outcomes in patients with ACS.

The usual administration of Aggramed involves an initial bolus injection followed by a continuous intravenous infusion. The exact dosage and duration of treatment are determined by the healthcare provider based on the patient's clinical condition and response to therapy. It is crucial to follow the prescribed regimen to achieve the desired therapeutic effect.

Common side effects of Aggramed may include bleeding, which is the most significant risk due to its antiplatelet activity. Other side effects can include low platelet count (thrombocytopenia), headache, and dizziness. Patients receiving Aggramed should be closely monitored for signs of bleeding and other adverse effects.

Aggramed is manufactured by Emcure Pharmaceuticals Ltd., a reputable pharmaceutical company known for its commitment to quality and patient care. Regular follow-ups and monitoring by healthcare providers are essential to ensure the safety and effectiveness of the treatment.

Aggramed Tirofiban Injection offers an effective intervention for managing acute coronary syndrome and preventing thrombotic complications during percutaneous coronary interventions. Its targeted action on platelet aggregation makes it a vital tool in cardiology, helping to reduce the risk of adverse cardiovascular events and improve patient outcomes. With its reliable manufacturing and proven efficacy, Aggramed is a trusted choice in the management of ACS and related conditions.

Nelabin 250 mg Injection contains Nelarabine, a chemotherapy medication used in the treatment of certain types of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Nelarabine is a prodrug of arabinosylguanine, which is converted inside the body to an active form that inhibits DNA synthesis in cancer cells, leading to cell death.

Nelabin is available in a strength of 250 mg per vial and is typically packaged as a single-use vial for intravenous administration. The intravenous form allows for direct delivery of the medication into the bloodstream, ensuring rapid and effective action against cancer cells.

The active ingredient, Nelarabine, interferes with the growth and proliferation of cancer cells by incorporating into their DNA and halting the replication process. This mechanism of action helps to reduce the number of cancerous cells in the body, contributing to the treatment and management of T-ALL and T-LBL.

The dosage and administration schedule of Nelabin are determined by the healthcare provider based on the patient's medical condition, body surface area, and response to treatment. It is crucial to follow the prescribed regimen precisely to achieve optimal results and minimize potential side effects.

Common side effects of Nelabin may include fatigue, nausea, vomiting, diarrhea, and decreased appetite. More serious side effects can occur, such as neurotoxicity, which may present as numbness, tingling, or weakness in the extremities. Regular monitoring by the healthcare provider is essential to manage any adverse effects and adjust the treatment as necessary.

Nelabin is manufactured by MSN Laboratories, a well-known pharmaceutical company dedicated to producing high-quality medications for various medical conditions. Patients receiving Nelabin should have regular follow-ups with their healthcare provider to monitor their response to the treatment and manage any side effects.

Nelabin 250 mg Injection offers an effective treatment option for patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Its targeted action against cancer cells helps to control the progression of these aggressive diseases, providing hope and improved outcomes for affected individuals. With its proven efficacy and reliable manufacturing, Nelabin is a trusted choice in oncology care.